UNIONDALE, N.Y. and ST. GALLEN, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN) and Vifor Pharma today announced completion of enrollment for Angion’s AKI-002 ...

ZURICH, March 3 (Reuters) - Swiss drugmaker Vifor Pharma VIFN.S is aiming to complete more acquisitions or licensing deals this year, Chief Executive Stefan Schulze told Reuters. "We would like to ...

EU antitrust regulators are investigating whether Vifor Pharma, which is being acquired by CSL Ltd, disparaged its rival Pharmacosmos in order to hinder competition to its blockbuster iron ...

(RTTNews) - Vifor Pharma announced positive outcome of the phase-IIIb DIAMOND trial of Veltassa in heart failure patients with either manifest hyperkalemia or with a history of hyperkalemia while ...

All regulatory clearances received for the acquisition of Vifor Pharma AG; Settlement of the offer is scheduled for 9 August 2022; Seasoned biopharma executive, Hervé Gisserot, designated to lead ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. CSL Ltd. (2019, June 20). Galenica Group focuses on pharmaceuticals as it becomes Vifor Pharma Group.

The logo of Swiss drugmaker Vifor Pharma is seen at the company's headquarters in Glattbrugg, Switzerland November 16, 2020. REUTERS/Arnd Wiegmann/File Photo Purchase Licensing Rights, opens new tab.